We found that among advanced lung adenocarcinoma patients, those carrying MALAT1 rs3200401 CT or CT + TT genotypes had significant longer survival time and decreased death risks than those carrying rs3200401 CC genotype. This evidence concerns the gene MALAT1 and lung adenocarcinoma.